| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO BASE (SNAP) USD DIS | RVI EMERGENTES | 42,35% | 64,02% | 31,37% | · |
| SCHRODER ISF US SMALL & MID-CAP EQUITY A1 ACC EUR | RVI USA SMALL/MID CAP | 20,50% | 26,53% | 31,37% | 103,69% |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | RVI BIOTECNOLOGÍA | 39,67% | 23,54% | 31,37% | · |
| BROWN ADVISORY US EQUITY GROWTH B EUR ACC | RVI USA CRECIMIENTO | -2,99% | 33,48% | 31,36% | 207,61% |
| CT (LUX) GLOBAL MULTI ASSET INCOME DU USD | MIXTO MODERADO GLOBAL | 10,34% | 25,34% | 31,36% | 51,40% |
| EDR SICAV-EQUITY EURO SOLVE CR EUR CAP | RVI EUROPA | 7,29% | 23,85% | 31,36% | · |
| BGF EMERGING MARKETS EQUITY INCOME A6 USD | RVI EMERGENTES | 46,40% | 56,04% | 31,35% | 96,05% |
| EDR SICAV-EQUITY EURO SOLVE K EUR CAP | RVI EUROPA | 7,29% | 23,85% | 31,35% | · |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO IO (SNAP) USD DIS | RVI EMERGENTES | 42,74% | 64,41% | 31,35% | · |
| AMUNDI FUNDS EUROPE EQUITY INCOME SELECT R2 EUR SATI (D) | RVI EUROPA | 4,43% | 24,18% | 31,34% | · |
